RxDoctor Payments Data

Meghan Parker

Psychiatric/Mental Health · Houston, TXNPI 1649035320

Payments from drug & device makers

$2,286in general payments, 2019–2025

Across 123 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$359
  • Alkermes, Inc.$357
  • Johnson & Johnson$222
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$195
  • Neurocrine Biosciences, Inc.$158
  • Lundbeck LLC$141
  • plus $853 from 16 others

What the payments were for

  • Food & beverage$2,286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,286 in reported general payments places this provider in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate26$90,395
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl19$1,964
Paliperidone ErPaliperidone19$1,766
Aripiprazole68$1,551
Bupropion XlBupropion Hcl69$1,415
Trazodone Hcl105$1,255
Oxcarbazepine20$851
Buspirone Hcl64$805
Duloxetine Hcl26$749
Sertraline Hcl57$717
Ziprasidone Hcl13$686
Hydroxyzine Hcl36$642
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$609
Clonazepam50$503
Alprazolam95$497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$222$90,39526 claims
Almatica Pharma LLCSertraline Hcl$32$71757 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →